title: Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment.
abstract: Skin and soft tissue infections rank among the most frequent infections worldwide. Classic erysipelas is defined as a non-purulent infection by beta-hemolytic streptococci. The typical signs are tender, warm, bright erythema with tongue-like extensions and early systemic symptoms such as fever or at least chills. Erysipelas always and best responds to penicillin. Limited soft tissue infection or limited cellulitis are the terms we have introduced for infections frequently caused by S. aureus and often originating from chronic wounds or acute trauma. Clinically, they are marked by tender, erythematous swelling which, unlike erysipelas, exhibit a darker red hue and is not always accompanied by fever or chills at onset. Severe cellulitis is a purulent, partially necrotic infection extending to the fascia, with general symptoms of infection, requiring surgical management in addition to antibiotics. It often fulfils criteria of so-called complicated soft tissue infections according to the definition of the FDA, due to their frequent association with e.g. severe diabetes mellitus, peripheral arterial occlusive disease or severe immunosuppression. In contrast, the rare necrotizing skin and soft tissue infections represent a distinct entity, characterized by rapid progression to ischemic necroses and shock due to special bacterial toxins. Limited cellulitis should be treated with cephalosporins group 1 or 2, or, when S.aureus is the isolated or highly likely causative agent, isoxazolyl-penicillins (exploiting their minimal selection pressure on other bacteria). For severe cellulitis, initial antibiotic treatment (mostly iv) includes - depending on the location - agents also active against gram-negative and/or anaerobic bacteria. (e.g. clindamycine, aminopeniclilline with inhibitors of betalaktamase, fluochinolons, cephalosporines group 4). For cutaneous abscesses, drainage presents the therapy of choice. Only under certain conditions additional antibiotic therapy is required. Adherence to the diagnostic criteria and to evidence-based or consensus-derived treatment recommendations as presented herein should allow for an antibiotic therapy with a good balance of efficacy, tolerability by patients and low selection pressure for highly resistant bacteria.
authors.affiliation: Department of Dermatology, University Hospital Münster and Division of Infectious Diseases in Dermatology, University of Münster.
authors.forename: Cord
authors.initials: C
authors.lastname: Sunderkötter
authors.affiliation: Institute for Medical Microbiology, University Hospital Münster.
authors.forename: Karsten
authors.initials: K
authors.lastname: Becker
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000145:classification; D015373:Bacterial Typing Techniques / Q000379:methods; D002908:Chronic Disease; D003131:Combined Modality Therapy; D046169:Dermoscopy / Q000379:methods; D004322:Drainage / Q000379:methods*; D004334:Drug Administration Schedule; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000379:methods; D012008:Recurrence; D017192:Skin Diseases, Bacterial / Q000175:diagnosis* / Q000382:microbiology / Q000628:therapy*; D018461:Soft Tissue Infections / Q000175:diagnosis* / Q000382:microbiology / Q000628:therapy*
chemical_list: D000900:Anti-Bacterial Agents